QAi Prostate Grade Receives Regulatory Approval from Abu Dhabi’s Department of Health

Singapore, July 28, 2025 — Qritive is pleased to announce that its AI-powered solution, QAi Prostate Grade, has received official market approval from the Department of Health – Abu Dhabi following a comprehensive Health Technology Assessment (HTA). This approval marks a major milestone in expanding the clinical use of artificial intelligence in prostate cancer diagnostics. 

Strengthening Diagnostic Confidence with AI in Abu Dhabi 

The approval allows QAi Prostate Grade to be used in specialized pathology laboratories in the Emirate of Abu Dhabi as a clinical decision support solution. The HTA process, recognized as a gold standard in evidence-based technology evaluation, placed a strong emphasis on clinical oversight, patient safety, and real-world applicability. 

With this regulatory milestone, Qritive reinforces its mission to deliver scalable and clinically validated AI solutions that enhance diagnostic accuracy, streamline workflows, and support timely, evidence-based care. 

Supporting Abu Dhabi’s Healthcare Innovation Vision 

Qritive is proud to contribute to Abu Dhabi’s growing vision for data-driven healthcare innovation, where regulatory frameworks support the safe and meaningful integration of new technologies. The approval of QAi Prostate Grade is a testament to the solution’s clinical value and the region’s commitment to advancing medical diagnostics through rigorous evaluation. 

See the Impact 

Below are sample visuals from the QAi Prostate Grade module, showing original pathology slides alongside AI-assisted grading outputs — demonstrating how the solution can support pathologists in clearly detecting and grading prostate cancer. 

Without AI Overlay

With QAi Prostate Grade Overlay

About Qritive

Headquartered in Singapore, with operations in the US and India, Qritive is a breakthrough Artificial Intelligence (AI) solution developer that is advancing digital pathology for cancer diagnosis and improving health outcomes. Qritive leverages deep learning technology to support the interpretation of pathology tests for time and resource-strapped pathologists, enabling faster diagnosis and reducing time to treatment for patients. Qritive is dedicated to empowering healthcare professionals across the globe with AI-powered solutions to operate collaboratively at the peak of their performance despite complexity and distance. 

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com